Bioequivalence study of a generic formulation of imatinib mesylate 400 mg filmcoated tablets versus Glivec® : a randomized open-label trial, single-dose, fasting, two-period, two-sequence crossover comparison in healthy Colombian volunteers.
Mauricio
Vargas,
Carlos
Bustamente
Visitas Artículo 306 |
Visitas PDF 334
15-21
|
Publicado: 2013-03-01